Moderators: Christopher D. Chaput, MD and Harvey E. Smith, MD
This panel discussion will review how our understanding of the efficacy and safety of BMP-2 evolved over time, as well as briefly review the YODA trials. Recent evidence regarding cancer risk, retrograde ejaculation, radiculitis, heterotopic bone formation, and osteolysis will be reviewed and contextualized for clinical practice. Panelists will share their thoughts on informed consent and the current use of BMP-2, given current understanding of the risks of the use of BMP-2.
Agenda
Introduction
All
Initial Clinical Use, Data, and Questions Raised
Eugene J. Carragee, MD
Overview of YODA Studies
Peter G. Whang, MD, FACS
Data post-YODA
Gregory D. Schroeder, MD
Clinical Usage of BMP-2 in 2019
Wellington K. Hsu, MD
Lessons Learned: Ongoing Review and Assessments of New Technology
Christopher D. Chaput, MD
Discussion, Questions & Answers